Boehringer Ingelheim Vetmedica’s (BIVI) new livestock vaccine research facility in Sioux Center, Iowa meets the company’s vision of Value Through Innovation, or VTI, according to Dr. Edward Robb, vice president of research and development for BIVI.
“The facility really allows us to test novel vaccine concepts to really see if these ideas can have an impact on the welfare of pigs and cattle,” he said. “To do and fund innovative research you have to work on ideas that will really change the way we do things.”
Robb says the new facility is also a good fit with their other locations in Iowa and St. Joseph, Missouri.
Listen to my interview with Dr. Robb here. Dr. Edward Robb at BIVI research facility dedication